# Product Identifiers under the Drug Supply Chain Security Act - Questions and Answers:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/product-identifiers-under-the-drug-supply-chain-security-act-questions-and-answers-guidance-for-industry/d3880c89-0e09-41de-baae-d56590db8510

> FDA guidance document: Product Identifiers under the Drug Supply Chain Security Act - Questions and Answers:  Guidance for Industry. Issue date: June 03, 2021. Get complete insights and analysis.

---

## Details

- Title: Product Identifiers under the Drug Supply Chain Security Act - Questions and Answers:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2021-06-03
- Last Changed: 2021-06-03
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-3175">FDA-2018-D-3175</a>

## Related Documents

- [Questions and Answers on Biosimilar Development and the BPCI Act Guidance for Industry:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/questions-and-answers-on-biosimilar-development-and-the-bpci-act-guidance-for-industry-guidance-for-industry/37eb8581-8678-45a9-bb8d-7e8754cae01a)
- [S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers](https://www.globalkeysolutions.net/guidances/guidance-document/s9-nonclinical-evaluation-for-anticancer-pharmaceuticals-questions-and-answers/5b838cf4-2c2e-4c10-8a24-439ce4ce61f1)
- [Product Development Under the Animal Rule](https://www.globalkeysolutions.net/guidances/guidance-document/product-development-under-the-animal-rule/e03ed1b9-cdb2-40a6-b4d6-28fc01609e6a)